Cargando…

Accuracy of an antigen-detecting SARS-CoV-2 assay with self- and provider-collected specimens interpreted visually and with BD Veritor™ Plus analyzer

BACKGROUND: SARS-CoV-2 rapid antigen tests (RATs) are in high demand for reducing the spread of SARS-CoV-2. Reduced involvement from health care professionals (HCPs) for collection and interpretation could significantly foster the wide-spread implementation of RATs, but data evaluating RATs, when us...

Descripción completa

Detalles Bibliográficos
Autores principales: Cooper, Lauren, Eckert, Karen, Mann, Joseph, Montalvo, Rossmeri, Castillo, Luis, Fellows, Dwan, Young, Stephen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Becton Dickinson and Company. Published by Elsevier Ltd. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846876/
https://www.ncbi.nlm.nih.gov/pubmed/36683609
http://dx.doi.org/10.1016/j.jcvp.2023.100140
_version_ 1784871296687931392
author Cooper, Lauren
Eckert, Karen
Mann, Joseph
Montalvo, Rossmeri
Castillo, Luis
Fellows, Dwan
Young, Stephen
author_facet Cooper, Lauren
Eckert, Karen
Mann, Joseph
Montalvo, Rossmeri
Castillo, Luis
Fellows, Dwan
Young, Stephen
author_sort Cooper, Lauren
collection PubMed
description BACKGROUND: SARS-CoV-2 rapid antigen tests (RATs) are in high demand for reducing the spread of SARS-CoV-2. Reduced involvement from health care professionals (HCPs) for collection and interpretation could significantly foster the wide-spread implementation of RATs, but data evaluating RATs, when used by lay people, is limited. OBJECTIVE: To valuate agreement between BD Veritor test results for self- and HCP-collected specimens, and visually- and analyzer-interpreted results. METHODS: Individuals with onset of COVID-19 symptoms within five days of enrollment had three nasal swabs collected; one self-collected and the other two HCP-collected. One HCP-collected swab was stored for future testing while the order of the other two (self and HCP) was randomized before testing. with the BD Veritor System for Rapid Detection of SARS-CoV-2. Results were first assessed visually, followed by interpretation with the analyzer. RESULTS: When self-collection was compared to HCP collection for SARS-CoV-2 detection, interpretation by analyzer resulted in positive percent agreement (PPA) of 94.7% (95% CI 82.7, 98.5) and negative percent agreement (NPA) of 99.0% (95% CI 97.5, 99.6). When visual interpretation was compared to analyzer-read results, collection by HCPs had a PPA of 97.4% (95% CI 86.5, 99.5) and NPA of 99.8% (95% CI 98.6, 100.0) while self-collection resulted in PPA of 94.9% (95% CI 83.1, 98.6) and NPA of 99.8% (95% CI 98.6, 100). CONCLUSIONS: Similar PPA and NPA were observed for self- and HCP-collected specimens as well as visually- and analyzer-interpreted tests. The equivalence in performance supports the use of expanded collection and testing methods.
format Online
Article
Text
id pubmed-9846876
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Becton Dickinson and Company. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-98468762023-01-18 Accuracy of an antigen-detecting SARS-CoV-2 assay with self- and provider-collected specimens interpreted visually and with BD Veritor™ Plus analyzer Cooper, Lauren Eckert, Karen Mann, Joseph Montalvo, Rossmeri Castillo, Luis Fellows, Dwan Young, Stephen J Clin Virol Plus Article BACKGROUND: SARS-CoV-2 rapid antigen tests (RATs) are in high demand for reducing the spread of SARS-CoV-2. Reduced involvement from health care professionals (HCPs) for collection and interpretation could significantly foster the wide-spread implementation of RATs, but data evaluating RATs, when used by lay people, is limited. OBJECTIVE: To valuate agreement between BD Veritor test results for self- and HCP-collected specimens, and visually- and analyzer-interpreted results. METHODS: Individuals with onset of COVID-19 symptoms within five days of enrollment had three nasal swabs collected; one self-collected and the other two HCP-collected. One HCP-collected swab was stored for future testing while the order of the other two (self and HCP) was randomized before testing. with the BD Veritor System for Rapid Detection of SARS-CoV-2. Results were first assessed visually, followed by interpretation with the analyzer. RESULTS: When self-collection was compared to HCP collection for SARS-CoV-2 detection, interpretation by analyzer resulted in positive percent agreement (PPA) of 94.7% (95% CI 82.7, 98.5) and negative percent agreement (NPA) of 99.0% (95% CI 97.5, 99.6). When visual interpretation was compared to analyzer-read results, collection by HCPs had a PPA of 97.4% (95% CI 86.5, 99.5) and NPA of 99.8% (95% CI 98.6, 100.0) while self-collection resulted in PPA of 94.9% (95% CI 83.1, 98.6) and NPA of 99.8% (95% CI 98.6, 100). CONCLUSIONS: Similar PPA and NPA were observed for self- and HCP-collected specimens as well as visually- and analyzer-interpreted tests. The equivalence in performance supports the use of expanded collection and testing methods. Becton Dickinson and Company. Published by Elsevier Ltd. 2023-02 2023-01-18 /pmc/articles/PMC9846876/ /pubmed/36683609 http://dx.doi.org/10.1016/j.jcvp.2023.100140 Text en © 2023 Becton Dickinson and Company Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Cooper, Lauren
Eckert, Karen
Mann, Joseph
Montalvo, Rossmeri
Castillo, Luis
Fellows, Dwan
Young, Stephen
Accuracy of an antigen-detecting SARS-CoV-2 assay with self- and provider-collected specimens interpreted visually and with BD Veritor™ Plus analyzer
title Accuracy of an antigen-detecting SARS-CoV-2 assay with self- and provider-collected specimens interpreted visually and with BD Veritor™ Plus analyzer
title_full Accuracy of an antigen-detecting SARS-CoV-2 assay with self- and provider-collected specimens interpreted visually and with BD Veritor™ Plus analyzer
title_fullStr Accuracy of an antigen-detecting SARS-CoV-2 assay with self- and provider-collected specimens interpreted visually and with BD Veritor™ Plus analyzer
title_full_unstemmed Accuracy of an antigen-detecting SARS-CoV-2 assay with self- and provider-collected specimens interpreted visually and with BD Veritor™ Plus analyzer
title_short Accuracy of an antigen-detecting SARS-CoV-2 assay with self- and provider-collected specimens interpreted visually and with BD Veritor™ Plus analyzer
title_sort accuracy of an antigen-detecting sars-cov-2 assay with self- and provider-collected specimens interpreted visually and with bd veritor™ plus analyzer
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846876/
https://www.ncbi.nlm.nih.gov/pubmed/36683609
http://dx.doi.org/10.1016/j.jcvp.2023.100140
work_keys_str_mv AT cooperlauren accuracyofanantigendetectingsarscov2assaywithselfandprovidercollectedspecimensinterpretedvisuallyandwithbdveritorplusanalyzer
AT eckertkaren accuracyofanantigendetectingsarscov2assaywithselfandprovidercollectedspecimensinterpretedvisuallyandwithbdveritorplusanalyzer
AT mannjoseph accuracyofanantigendetectingsarscov2assaywithselfandprovidercollectedspecimensinterpretedvisuallyandwithbdveritorplusanalyzer
AT montalvorossmeri accuracyofanantigendetectingsarscov2assaywithselfandprovidercollectedspecimensinterpretedvisuallyandwithbdveritorplusanalyzer
AT castilloluis accuracyofanantigendetectingsarscov2assaywithselfandprovidercollectedspecimensinterpretedvisuallyandwithbdveritorplusanalyzer
AT fellowsdwan accuracyofanantigendetectingsarscov2assaywithselfandprovidercollectedspecimensinterpretedvisuallyandwithbdveritorplusanalyzer
AT youngstephen accuracyofanantigendetectingsarscov2assaywithselfandprovidercollectedspecimensinterpretedvisuallyandwithbdveritorplusanalyzer